Empowering Cancer Patients Through Innovations in Information Technology-Based Reporting of Precision Medicine

通过基于信息技术的精准医学报告创新为癌症患者提供帮助

基本信息

  • 批准号:
    9224605
  • 负责人:
  • 金额:
    $ 15万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-09-30 至 2018-09-29
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY The introduction of large-scale genomic testing in medicine promises to transform patient care. Cancer is at the leading edge of this revolution and hundreds of thousands of cancer patients receive tumor genomic testing yearly. Despite rapid adoption of genomic testing in cancer, many patients fail to comprehend basic genetic concepts and the defining genomic characteristics of their disease. Given that better-informed patients can more effectively engage in their care, and that greater knowledge is associated with improved cancer-related outcomes, there are significant concerns that patients' genomic knowledge deficits will contribute to poor quality care and outcomes. In this context there is an urgent need to educate patients about cancer genomics generally, and their sequencing results specifically, in a format that is usable, useful, and that easily integrates into existing clinical workflows. We propose to address this gap in care quality by identifying patients' needs for sequencing information and using that knowledge to design a dynamic, patient-facing, web-based cancer genome sequencing report that will integrate with the electronic health record (Aim 1). During the design process, we will elicit input from cancer patients, family members and clinicians to ensure that the web report is useful, usable, and that it easily integrates into clinical workflows. In the second phase, we will evaluate the feasibility and acceptability of delivering sequencing results and genomic education via the web report to cancer patients treated in academic and community settings (Aim 2). On completion of this project, we will be well positioned to test the effectiveness of the web-based patient sequencing report in a full-scale implementation trial. We hypothesize that when the web report is used to augment the return of cancer genome sequencing results, 1) it will increase patients' knowledge, their ability to actively participate in care, and their ability to share genomic information with family members; 2) it will increase oncologists' recommendations for genomically targeted therapies; and 3) it will improve patient-provider communication, care satisfaction and the efficiency of care delivery. This pilot and feasibility health IT project, addressing the Agency for Healthcare Research and Quality's Design Research Area, will leverage the IT network that we have developed which stores genome- sequencing data; generates dynamic, physician-directed reports; and matches patients to relevant clinical trials. Our commitment to open source development will allow universal access to the source code and facilitate widespread dissemination of the web-based patient sequencing report and IT network. By providing patients with direct access to their sequencing results, we aim to ensure that they understand the essential genomic characteristics of their disease and give them the knowledge that they need to actively participate in cancer care decisions. If successful, the project will facilitate patient engagement in care and serve as a critical step forward in the goal to improve the quality of cancer care delivery.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Stacy W. Gray其他文献

Factors In�uencing Cancer Genetic Somatic Mutation Test Ordering By Cancer Physicians
诱发癌症的因素 癌症医生安排的遗传体细胞突变测试
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Anastassia Demeshko;D. Pennisi;Stacy W. Gray;Matthew A. Brown;A. McInerney
  • 通讯作者:
    A. McInerney

Stacy W. Gray的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Stacy W. Gray', 18)}}的其他基金

Development of Family1st-An interactive web-based tool with evidence-based approaches to communicate hereditary cancer risk to at risk relatives and promote cascade testing.
Family1st 的开发 - 一种基于网络的交互式工具,采用基于证据的方法向高危亲属传达遗传性癌症风险并促进级联测试。
  • 批准号:
    10508426
  • 财政年份:
    2022
  • 资助金额:
    $ 15万
  • 项目类别:
Scalable tools to effectively translate genomic discoveries into the clinic
可扩展的工具可有效地将基因组发现转化为临床
  • 批准号:
    9815293
  • 财政年份:
    2019
  • 资助金额:
    $ 15万
  • 项目类别:
Scalable tools to effectively translate genomic discoveries into the clinic
可扩展的工具可有效地将基因组发现转化为临床
  • 批准号:
    10657370
  • 财政年份:
    2019
  • 资助金额:
    $ 15万
  • 项目类别:
Scalable tools to effectively translate genomic discoveries into the clinic
可扩展的工具可有效地将基因组发现转化为临床
  • 批准号:
    10425395
  • 财政年份:
    2019
  • 资助金额:
    $ 15万
  • 项目类别:
Scalable tools to effectively translate genomic discoveries into the clinic
可扩展的工具可有效地将基因组发现转化为临床
  • 批准号:
    10204071
  • 财政年份:
    2019
  • 资助金额:
    $ 15万
  • 项目类别:

相似国自然基金

中国北方人群肺癌患者Cancer/Testis抗原表达谱绘制表位鉴定及功能性抗原特异性CTL制备研究
  • 批准号:
    81673007
  • 批准年份:
    2016
  • 资助金额:
    54.0 万元
  • 项目类别:
    面上项目

相似海外基金

e-health tools to promote Equality in Quality of Life for childhood to young adulthood cancer patients, survivors and their families - a PanEuropean project supported by PanCare and Harmonic consortia
电子医疗工具可促进儿童到成年癌症患者、幸存者及其家人的生活质量平等 - 这是由 PanCare 和 Harmonic 联盟支持的 PanEuropean 项目
  • 批准号:
    10098114
  • 财政年份:
    2024
  • 资助金额:
    $ 15万
  • 项目类别:
    EU-Funded
Epigenomic Methods to Improve Personalised Treatment in Patients with Lung Cancer and Malignant Pleural Effusion.
表观基因组方法改善肺癌和恶性胸腔积液患者的个体化治疗。
  • 批准号:
    MR/X030938/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15万
  • 项目类别:
    Research Grant
An innovative minimally invasive, active medical device platform for remote neurological monitoring of brain cancer patients to aid treatment/care
创新的微创主动医疗设备平台,用于对脑癌患者进行远程神经学监测,以帮助治疗/护理
  • 批准号:
    10099579
  • 财政年份:
    2024
  • 资助金额:
    $ 15万
  • 项目类别:
    Collaborative R&D
Detection of novel therapeutic targets and biomarkers via identification of beneficial oral/ gut bacteria to enhance the response of PD1/PD-L1 blockade therapy in oral cancer patients
通过鉴定有益的口腔/肠道细菌来检测新的治疗靶点和生物标志物,以增强口腔癌患者 PD1/PD-L1 阻断疗法的反应
  • 批准号:
    24K13070
  • 财政年份:
    2024
  • 资助金额:
    $ 15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
EUonQoL: Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe
EUonQoL:肿瘤学生活质量:衡量欧洲癌症患者和幸存者的重要因素
  • 批准号:
    10057589
  • 财政年份:
    2023
  • 资助金额:
    $ 15万
  • 项目类别:
    EU-Funded
Living in limbo: The Experience of and Relationship between Fear of Progression, Illness Uncertainty, Symptom Burden, and Death Anxiety in Patients with Advanced or Metastatic Lung Cancer Receiving Immunotherapy or Targeted Therapy
生活在不确定之中:接受免疫治疗或靶向治疗的晚期或转移性肺癌患者对病情进展的恐惧、疾病的不确定性、症状负担和死亡焦虑的经历和关系
  • 批准号:
    478587
  • 财政年份:
    2023
  • 资助金额:
    $ 15万
  • 项目类别:
    Operating Grants
EPIphANy (Evaluation of Pharmacological Interactions with Anticoagulants in caNcer patients) program - prostate cancer cohort
EPIPHANy(癌症患者抗凝药理相互作用的评估)计划 - 前列腺癌队列
  • 批准号:
    479295
  • 财政年份:
    2023
  • 资助金额:
    $ 15万
  • 项目类别:
    Operating Grants
Randomized controlled trial of in-person and virtual Symptom screening with Targeted Early Palliative care (STEP2) in patients with advanced cancer
对晚期癌症患者进行有针对性的早期姑息治疗 (STEP2) 进行现场和虚拟症状筛查的随机对照试验
  • 批准号:
    490098
  • 财政年份:
    2023
  • 资助金额:
    $ 15万
  • 项目类别:
    Operating Grants
Attempt to stratify gastric cancer patients by AI using general clinical information
尝试利用一般临床信息通过人工智能对胃癌患者进行分层
  • 批准号:
    23K08102
  • 财政年份:
    2023
  • 资助金额:
    $ 15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
stablishment of non-invasive DNA methylation panel for peritoneal metastasis of gastric cancer patients
胃癌腹膜转移非侵入性DNA甲基化检测试剂盒的建立
  • 批准号:
    23K08210
  • 财政年份:
    2023
  • 资助金额:
    $ 15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了